{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:05:02Z","timestamp":1790006702610,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006512","name":"School of Medicine, Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.rpth.2026.106924","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:54:51Z","timestamp":1787921691000},"page":"106924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extravascular factor IX: a semicentennial narrative review"],"prefix":"10.1016","volume":"10","author":[{"given":"Tvisha","family":"Subhasish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-1418","authenticated-orcid":false,"given":"Christopher R.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106924_bib1","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.2023023276","article-title":"Blood coagulation factor IX: structural insights impacting hemophilia B therapy","volume":"144","author":"Bos","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106924_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/iub.70024","article-title":"Blood coagulation factor IX: structure, function, and regulation","volume":"77","author":"Ivanciu","year":"2025","journal-title":"IUBMB Life"},{"key":"10.1016\/j.rpth.2026.106924_bib3","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bmj.2.4799.1378","article-title":"Christmas disease: a condition previously mistaken for haemophilia","volume":"2","author":"Biggs","year":"1952","journal-title":"Br Med J"},{"key":"10.1016\/j.rpth.2026.106924_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.23645","article-title":"Mutation analysis of a cohort of US patients with hemophilia B","volume":"89","author":"Li","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2026.106924_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00194400","article-title":"Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation","volume":"46","author":"Bj\u00f6rkman","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rpth.2026.106924_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI104789","article-title":"The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans","volume":"42","author":"Adelson","year":"1963","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rpth.2026.106924_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood.V58.3.625.625","article-title":"Labeled factor IX kinetics in patients with hemophilia-B","volume":"58","author":"Smith","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106924_bib8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1160\/TH14-06-0505","article-title":"Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liability","volume":"113","author":"Metzger","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-5223(98)00437-1","article-title":"Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass","volume":"116","author":"Spanier","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rpth.2026.106924_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/hs0202.102950","article-title":"Inhibition of factor IX(a) is protective in a rat model of thromboembolic stroke","volume":"33","author":"Toomey","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2026.106924_bib11","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1073\/pnas.80.13.4119","article-title":"Binding of factors IX and IXa to cultured vascular endothelial cells","volume":"80","author":"Stern","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2026.106924_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0006-291X(83)90365-0","article-title":"Binding of coagulation factors IX and X to the endothelial cell surface","volume":"111","author":"Heimark","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.rpth.2026.106924_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1073\/pnas.81.3.913","article-title":"Activation of factor IX bound to cultured bovine aortic endothelial cells","volume":"81","author":"Stern","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2026.106924_bib14","doi-asserted-by":"crossref","first-page":"16242","DOI":"10.1016\/S0021-9258(17)36227-0","article-title":"Relationships within the family of GTP-binding proteins isolated from bovine central nervous system","volume":"260","author":"Roof","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106924_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.1987.tb01303.x","article-title":"In vivo evidence of intravascular binding sites for coagulation factor IX","volume":"66","author":"Stern","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106924_bib16","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.93.20.11068","article-title":"Identification of the endothelial cell binding site for factor IX","volume":"93","author":"Cheung","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2026.106924_bib17","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1016\/S0021-9258(18)31517-5","article-title":"The role of the epidermal growth factor-1 and hydrophobic stack domains of human factor IX in binding to endothelial cells","volume":"266","author":"Cheung","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106924_bib18","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/S0021-9258(18)52263-8","article-title":"The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region","volume":"266","author":"Astermark","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106924_bib19","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1021\/bi00121a031","article-title":"The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domain","volume":"31","author":"Toomey","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.rpth.2026.106924_bib20","doi-asserted-by":"crossref","first-page":"20529","DOI":"10.1016\/S0021-9258(19)36713-4","article-title":"The binding of human factor IX to endothelial cells is mediated by residues 3-11","volume":"267","author":"Cheung","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106924_bib21","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.1074\/jbc.272.27.16717","article-title":"Human factor IX binds to specific sites on the collagenous domain of collagen IV","volume":"272","author":"Wolberg","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rpth.2026.106924_bib22","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","article-title":"A coagulation factor IX-deficient mouse model for human hemophilia B","volume":"90","author":"Lin","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106924_bib23","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1182\/blood-2004-01-0138","article-title":"Creation of a mouse expressing defective human factor IX","volume":"104","author":"Jin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106924_bib24","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/j.1538-7836.2009.03545.x","article-title":"Abnormal hemostasis in a knock-in mouse carrying a variant of factor IX with impaired binding to collagen type IV","volume":"7","author":"Gui","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2016-01-696104","article-title":"Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice","volume":"128","author":"Cooley","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106924_bib26","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1182\/blood.2018884015","article-title":"Dysfunctional endogenous FIX impairs prophylaxis in a mouse hemophilia B model","volume":"133","author":"Cooley","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106924_bib27","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1111\/jth.15069","article-title":"Tissue distribution of rIX-FP after intravenous application to rodents","volume":"18","author":"Herrmann","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.thromres.2014.02.010","article-title":"Biodistribution of the recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in rats","volume":"133","author":"Herzog","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2026.106924_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MBC.0000000000001230","article-title":"Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice","volume":"34","author":"van der Flier","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2026.106924_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.omtn.2021.12.011","article-title":"Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO","volume":"27","author":"Reed","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.rpth.2026.106924_bib31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/a-2090-9739","article-title":"Modulation of extravascular binding of recombinant factor IX impacts the duration of efficacy in mouse models","volume":"123","author":"Machado","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtha.2023.11.023","article-title":"Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding","volume":"22","author":"Leuci","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib33","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/psp4.13159","article-title":"PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space","volume":"13","author":"Cloesmeijer","year":"2024","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.rpth.2026.106924_bib34","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.jtha.2025.07.036","article-title":"Protease domain exosites regulate extravascular binding of factor IX(a)","volume":"23","author":"Westmark","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib35","first-page":"693","article-title":"Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats","volume":"22","author":"Chang","year":"2008","journal-title":"In Vivo"},{"key":"10.1016\/j.rpth.2026.106924_bib36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/jth.12960","article-title":"Selective disruption of heparin and antithrombin-mediated regulation of human factor IX","volume":"13","author":"Westmark","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib37","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1038\/s41467-025-62955-9","article-title":"Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties","volume":"16","author":"Aaen","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.rpth.2026.106924_bib38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa0904377","article-title":"X-linked thrombophilia with a mutant factor IX (factor IX Padua)","volume":"361","author":"Simioni","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.rpth.2026.106924_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41591-025-04012-y","article-title":"Factor IX-Padua AAV gene therapy in hemophilia B: phases 1\/2 and 3 trials","volume":"32","author":"Xue","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.rpth.2026.106924_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0580","article-title":"An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics","volume":"12","author":"Bern","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rpth.2026.106924_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.17559","article-title":"Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity","volume":"194","author":"Lombardi","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106924_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2026.106862","article-title":"Extravascular distribution of factor IX\u2014review of experimental and clinical evidence, and relevance for hemophilia B replacement therapy","volume":"10","author":"Hermans","year":"2026","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.rpth.2026.106924_bib43","article-title":"Extravascular factor IX activity varies across tissue types [abstract]","volume":"9","author":"Subhasish","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106924_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ar.10162","article-title":"Evolution of collagens","volume":"268","author":"Exposito","year":"2002","journal-title":"Anat Rec"},{"key":"10.1016\/j.rpth.2026.106924_bib45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","article-title":"Collagen structure and stability","volume":"78","author":"Shoulders","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.rpth.2026.106924_bib46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/blood.V100.1.153","article-title":"Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo","volume":"100","author":"Gui","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106924_bib47","doi-asserted-by":"crossref","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"UniProt: the Universal Protein Knowledgebase in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792603582X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247503792603582X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:29:49Z","timestamp":1790004589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247503792603582X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S247503792603582X"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106924","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extravascular factor IX: a semicentennial narrative review","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106924"}}